Citigroup Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $23

Benzinga Newsdesk www.benzinga.com Neutral 53.7%

Neg 0% Neu 53.7% Pos 0%

Citigroup analyst Joanne Wuensch initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $23.